ON THE ISSUE OF EXPANDING THE INDICATIONS OF THE USE OF AN IMMUNOMODULATING DRUG IN THE TREATMENT AND PREVENTION OF INFLUENZA AND ACUTE RESPIRATORY INFECTIONS IN YOUNG CHILDREN

ON THE ISSUE OF EXPANDING THE INDICATIONS OF THE USE OF AN IMMUNOMODULATING DRUG IN THE TREATMENT AND PREVENTION OF INFLUENZA AND ACUTE RESPIRATORY INFECTIONS IN YOUNG CHILDREN

The data on the safety and effectiveness of the use of the domestic immunomodulating preparation Polyoxidonium® (azoximer bromide) in children are summarized in the following pages. Polyoxidonium has an immunomodulatory (including interferon-inducing), detoxication and anti-inflammatory effect that...

Full description

Bibliographic Details
Main Author:	V. F. Uchaikin
Format:	Article
Language:	Russian
Published:	LLC "Diagnostics and Vaccines" 2017-09-01
Series:	Детские инфекции (Москва)
Subjects:	acute respiratory infections (ari) azoximer bromide polyoxidonium® immunomodulator children
Online Access:	https://detinf.elpub.ru/jour/article/view/309

Similar Items

Potential of azoximere bromide for treatment of patients with acute inflammatory and infectious upper respiratory diseases
by: Valery M. Svistushkin, et al.
Published: (2023-12-01)

Role of immunocorrection therapy in comprehensive treatment of patients with inflammatory diseases of female genital organs
by: Natalia A. Shchukina, et al.
Published: (2020-05-01)

THE ROLE OF MODERN IMMUNOMODULATORS IN TREATMENT AND PREVENTION OF UPPER RESPIRATORY TRACT AND EAR DISEASES
by: A. A. Krivopalov, et al.
Published: (2017-11-01)

Enhancement of the Yersinia pestis EV NIIEG Vaccine Srain Immunogenic and Protective Activity under Cultivation with Azoxymer Bromide (Polyoxidonium)
by: T. N. Shchukovskaya, et al.
Published: (2022-01-01)

Azoximer bromide-modulated immune response in aerobic vaginitis
by: G. B. Dikke, et al.
Published: (2022-01-01)

Use of azoximer bromide for treatment of children's inflammatory infections of respiratory system: a meta-analysis of controlled clinical studies
by: A. V. Karaulov, et al.
Published: (2019-12-01)

Rational immunotherapy in the combination treatment of community-acquired pneumonia
by: G. A. Mavzyutova, et al.
Published: (2015-12-01)

PROBIOTICS AND BACTERIAL IMMUNOMODULATORS FOR PREVENTION OF RESPIRATORY INFECTIONS
by: N. V. Khoroshilova
Published: (2014-07-01)

Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency
by: Mikhail P. Kostinov, et al.
Published: (2020-11-01)

Experience of medical professionals with Azoximer bromide as prophylactic treatment for COVID-19 patients in Chuvashia Republic, Russia
by: S. Efimov
Published: (2021-08-01)

Influence of immunomodulation on intracellular cytokine expression by spleen T-helpers of mice immunized by Yersinia pestis EV NIIEG
by: S. N. Klyueva, et al.
Published: (2021-05-01)

Application of Polyoxidonium in the Mixed Treatment of Experimental Plague Generalized Forms
by: T. A. Bondareva, et al.
Published: (2009-02-01)

Expression of Toll-like Receptors on the Immune Cells in Patients with Common Variable Immune Deficiency after Different Schemes of Influenza Vaccination
by: Aristitsa Mikhailovna Kostinova, et al.
Published: (2023-10-01)

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine. [version 1; peer review: 2 approved]
by: Susanna Kharit, et al.
Published: (2022-03-01)

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine. [version 2; peer review: 2 approved]
by: Susanna Kharit, et al.
Published: (2022-11-01)

IMMUNOMODULATORY THERAPY IN PATIENTS WITH UPPER RESPIRATORY TRACT INFECTIONS AND UPPER RESPIRATORY TRACT
by: E. F. Glushkova, et al.
Published: (2016-12-01)

Frequent respiratory viral infections in children. What should be done?
by: G. N. Nikiforova, et al.
Published: (2016-12-01)

Immunomodulatory therapy in ENT practice
by: D. M. Mustafaev, et al.
Published: (2016-12-01)

Comparison of Post-Vaccination Cellular Immune Response in Patients with Common Variable Immune Deficiency
by: Aristitsa Mikhailovna Kostinova, et al.
Published: (2024-07-01)

Azoximer bromide and hydroxyapatite: promising immune adjuvants in cancer
by: Jean-François Rossi, et al.
Published: (2023-12-01)

Efficacy of azoximer bromide in the treatment of hospitalized patients with moderate to severe community-acquired pneumonia
by: S. K. Zyryanov, et al.
Published: (2021-12-01)

Evaluation of the Preventive Efficacy and Safety of Azoximer Bromide in Healthcare Workers in Contact with Patients Hospitalized for COVID-19
by: K V Kasyanenko, et al.
Published: (2022-03-01)

Possibilities of using multidirectional immunomodulators for acute and recurrent infectious and inflammatory diseases of the upper respiratory tract
by: S. V. Morozova, et al.
Published: (2021-04-01)

WHICH IMMUNOMODULATORS ARE INDICATED TO FREQUENTLY ILL CHILDREN? FROM UNDERSTANDING OF MECHANISMS OF ACTION TO CLINICAL EFFICACY
by: A. V. Karaulov
Published: (2014-01-01)

Neutrophil extracellular traps as an important part of the pathogenesis of chronic rhinosinusitis without polyps
by: Valery М. Svistushkin, et al.
Published: (2024-10-01)

Use of immunomodulatory therapy as part of comprehensive treatment of non-severe community-acquired pneumonia and its long-term results
by: Mikhail P Kostinov, et al.
Published: (2023-08-01)

Experience of using immunomodulatory therapy in the complex treatment of mild community-acquired pneumonia and its long-term results
by: M. P. Kostinov, et al.
Published: (2024-04-01)

TOPICAL IMMUNOMODULATOR IN PROPHYLAXIS AND TREATMENT OF ACUTE RESPIRATORY INFECTIONS IN CHILDREN
by: V. V. Chernikov
Published: (2012-07-01)

ON THE ISSUE OF CHANGING THE MORPHOLOGY OF THE SPLEEN IN NEMATODOSES IN MICE DURING IMMUNOSTIMULATION
by: Olga B. Zhdanova, et al.
Published: (2023-06-01)

Evaluation of azoximer bromide (polyoxidonium) influence on the adhesive properties of the Yersinia pestis EV NIIEG vaccine strain by atomic force microscopy
by: T. N. Shchukovskaya, et al.
Published: (2021-07-01)

House environmental conditions with the event of acute respiratory infection (ARI) in toddlers in Indonesian: A meta-analysis
by: Muhammad Addin Rizaldi
Published: (2023-02-01)

Possibilities of therapy for neuropathic pain caused by chemo-induced polyneuropathy
by: Svetlana V. Chubykina, et al.
Published: (2024-08-01)

Immunorehabilitation Children with Impaired Health Status
by: O. V. Shamsheva, et al.
Published: (2016-06-01)

Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials
by: R. Kompier
Published: (2018-09-01)

The effects of synthetic immunostimulator polyoxidonium on methotrexate treatment in rats with adjuvant arthritis
by: Jozef Rovenský, et al.
Published: (2011-12-01)

PM10 and Acute Respiratory Infection (ARI) in Furniture Industry Workers
by: Yusnabeti Yusnabeti, et al.
Published: (2011-02-01)

Risk analysis of temperature, humidity, ventilation, use of mosquito repellent, and smoking behaviour on the incidence of acute respiratory infections (ARI) in Toddlers
by: Putri Ziha Nabiha, et al.
Published: (2024-01-01)

THE EFFECTIVENESS OF A NATURAL PREPARATION IN THE TREATMENT AND PREVENTION OF INFLUENZA AND OTHER ACUTE RESPIRATORY DISEASES IN CHILDREN
by: O. V. Shamsheva, et al.
Published: (2017-12-01)

An innovative approach to the prevention and treatment of acute respiratory tract infections in children
by: I. A. Larkova, et al.
Published: (2022-04-01)

Clinical and economic assessment of using topical bacterial lysate Imudon® for the treatment and prevention of acute upper respiratory tract infections in children
by: A. R. Kasimova, et al.
Published: (2024-08-01)